Stock & Company Details
InflaRx N.V. $IFRX
Price:
N/A
N/A
15M
$255M
52 Week High:
N/A
10 Day Average Volume:
N/A
-3.64
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
IFRX technical indicators
Latest InflaRx N.V. (IFRX) indicator readings as of 2026-10-29.
IFRX's 14-day RSI is 53.6, in neutral territory. At $1.72 it is trading 5.0% above its 200-day moving average of $1.63, and below its 50-day average of $1.88. Price sits near the upper Bollinger Band ($1.37 to $1.77). ADX reads 25.2, indicating a trending market.
Overview
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
Finance Bot
Ask your questions
Start by typing a question below.
